Showing results (11-20 of 543) with videos related to
Sort By:
Pageof 55
British Journal of Cancer|December 1, 1992
IL2 treatment for cancer: from biology to gene therapyR Foa, A Guarini, B GansbacherJournal of Clinical & Laboratory Immunology|October 1, 1984
In vitro generation of NK-like activity in human PBL co-cultured with fresh T leukaemia cellsL Matera, R Foa, M MooreBritish Journal of Haematology|September 1, 1978
Cell membrane enzymes. II. Alkaline phosphatase and alkaline phosphodiesterase I in normal and leukaemic lymphocytesM T Kramers, D Catovsky, R FoaInternational Journal of Clinical & Laboratory Research|January 1, 1994
Taxol (paclitaxel): a novel anti-microtubule agent with remarkable anti-neoplastic activityR Foa, L Norton, A D SeidmanExperientia|February 15, 1979
Alkaline phosphatase in human lymphocyte subpopulationsR Foa, M T Kramers, D CatovskyImmunology|September 1, 1980
Inhibition of T-lymphocyte colony formation by inhibitors of mitochondrial protein synthesisR Foa, M N Zafar, D CatovskyBritish Journal of Haematology|December 1, 1985
Monoclonal antibody OKT17 recognizes most cases of T-cell malignancyE Matutes, A Parreira, R Foa, et al.Minerva Medica|March 31, 1981
[Use of betamethasone in heart surgery]A Tempia, F Cerutti, D Vercelli, et al.Leukemia Research|January 1, 1982
Reduced T-colony forming capacity in B-chronic lymphocytic leukaemia.--II. Correlation with clinical stage and findings in B-prolymphocytic leukaemiaR Foa, F Lauria, D Catovsky, et al.Blood|March 15, 1996
Retroviral vector-mediated transfer of the tumor necrosis factor alpha gene into human cancer cells restores an apoptotic cell death program and induces a bystander-killing effectA Gillio Tos, A Cignetti, G Rovera, et al.Pageof 55